Differences between DSM-IV and DSM-5 as applied to child and adolescent psychiatry and neurodevelopmental disorders

2017 ◽  
Vol 35 (2) ◽  
pp. 143-149
Author(s):  
Z. Shujah ◽  
A. Mulligan
Keyword(s):  
Adolescent Psychiatry ◽  
Relevant Literature ◽  
Child And Adolescent ◽  
Autism Spectrum ◽  
Child And Adolescent Psychiatry ◽  
Statistical Manual ◽  
Hyperactivity Disorder ◽  
Diagnostic And Statistical Manual ◽  
Dsm 5 ◽  
Dsm Iv

Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) was published by the American Psychiatric Association in 2013. We discuss the important differences between DSM-IV and DSM-5 with particular relevance to child and adolescent psychiatry. The DSM-5 diagnostic criteria for a diagnosis of autism spectrum disorder and of attention-deficit/hyperactivity disorder are discussed in detail, as well as a summary of other changes in DSM-5 relevant to child and adolescent psychiatry. The discussion is supported by a review of relevant literature.

scholarly journals Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol

BMJ Open ◽  
2018 ◽  
Vol 8 (2) ◽  
pp. e020434
Author(s):  
Sufei He ◽  
Miao Wang ◽  
Jinhua Si ◽  
Tianyi Zhang ◽  
Hong Cui ◽  
...  
Keyword(s):  
Systematic Review ◽  
Rating Scale ◽  
Controlled Trials ◽  
Efficacy And Safety ◽  
Statistical Manual ◽  
Hyperactivity Disorder ◽  
Diagnostic And Statistical Manual ◽  
Dsm 5 ◽  
Icd 10 ◽  
Dsm Iv

IntroductionAttention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated childhood psychiatric disorders. The analogous diagnosis adopted in Europe is hyperkinetic disorder, which is defined in the WHO’s International Classification of Diseases 10th edition (ICD-10). Hyperkinetic disorder includes more severe conditions. Ginkgo preparations are used in the treatment of ADHD. The present study will assess the efficacy and safety of ginkgo preparations in the treatment of ADHD in the currently published literature.Materials and methodsAll prospective randomised controlled trials (RCTs) will be included in this systematic review. Patients diagnosed with ADHD according to American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV), Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), ICD-10 or Chinese Classification and Diagnosis of Mental Diseases third edition (CMDD) will be included. A comprehensive search for RCTs to evaluate the effectiveness and tolerance of ginkgo preparations will be performed. The primary outcomes are the ADHD Rating Scale-IV and Revised Conners’ Parent Rating Scale. The secondary outcomes are quality of life evaluated by the KINDL scale, adverse effects/events, Conners’ Teacher Rating Scale, Strengths and Weaknesses of ADHD Symptoms and Normal Behaviour Scale and Fremdbeurteilungsbogen für Hyperkinetische Störungen. Exclusion criteria are the following: (1) case reports, not randomised trial, non-comparative studies and (2) patients who were not diagnosed based on DSM-IV, DSM-5, ICD-10 or CMDD. The following databases will be searched from their inception until January 2018: Medline, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, China Biology Medicine Disc, China National Knowledge Infrastructure Database, Wanfang Database and Chinese Scientific Journals Database. Two authors will independently perform the study selection, extract the data and assess the study quality and risk of bias.Ethics and disseminationThis systematic review does not require ethics approval. It will be published in a peer-reviewed journal.PROSPERO registration numberCRD42017077190.

The Use of Mobile and Wearable Artificial Intelligence in Child and Adolescent Psychiatry – A Scoping Review (Preprint)

2021 ◽  
Author(s):  
Victoria Welch ◽  
Tom Joshua Wy ◽  
Anna Ligezka ◽  
Leslie C. Hassett ◽  
Paul E. Croarkin ◽  
...  
Keyword(s):  
Mental Health ◽  
Artificial Intelligence ◽  
Scoping Review ◽  
Adolescent Psychiatry ◽  
Child And Adolescent ◽  
Mental Health Disorders ◽  
Wearable Devices ◽  
Autism Spectrum ◽  
Child And Adolescent Psychiatry ◽  
Health Disorders

BACKGROUND Mental health disorders across the life span are a leading cause of medical disabilities. This burden is particularly significant in children and adolescents due to challenges in diagnoses and lack of precision medicine approaches. The advent and widespread adoption of wearable devices (e.g., smartwatches) that generate large volumes of passively collected data that are conducive for artificial intelligence applications to remotely diagnose and manage child and adolescent mental health disorders is promising. OBJECTIVE This study conducted a scoping review to study, characterize and identify areas of innovations with wearable devices that can augment current in-person physician assessments to individualize diagnosis and management of mental health disorders in child and adolescent psychiatry. METHODS This scoping review used PRISMA’s information as a guide. A comprehensive search of several databases from 2011 to June 25, 2021, limited to English language and excluding animal studies, was conducted. The databases included Ovid MEDLINE (R) and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily, Ovid Embase, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, Web of Science, and Scopus. RESULTS The initial search yielded 344 articles. 19 articles were left on the final source list for this scoping review. Articles were divided into three main groups: Studies with the main focus on Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorders (ADHD) and Internalizing disorders such as anxiety disorders. Majority of the studies used either ECG strap or wrist worn biosensor. CONCLUSIONS Our scoping review found large heterogeneity of methods and findings in artificial intelligence studies in child psychiatry. Overall, the largest gaps identified in this scoping review are the lack of randomized control trials, most available studies are pilot feasibility trials.

scholarly journals Prevalence and stability of insomnia from preschool to early adolescence: a prospective cohort study in Norway

2020 ◽  
Vol 4 (1) ◽  
pp. e000660
Author(s):  
Jonas Falch-Madsen ◽  
Lars Wichstrøm ◽  
Ståle Pallesen ◽  
Silje Steinsbekk
Keyword(s):  
Sex Differences ◽  
Cohort Study ◽  
Early Adolescence ◽  
Community Sample ◽  
Statistical Manual ◽  
Diagnostic And Statistical Manual ◽  
Dsm 5 ◽  
Parents And Children ◽  
Dsm Iv ◽  
Time Point

BackgroundThere is limited knowledge about the prevalence and stability of insomnia defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM). We therefore provide such estimates from preschool to early adolescence and explore potential sex differences.MethodsWe followed a representative community sample (n=1037) biennially from 4 to 14 years of age (2007–2017). Insomnia diagnoses and symptoms were captured by a semistructured clinical interview of parents and children (from age 8 years).ResultsAt ages 4 and 6 years approximately 2.5% of children met the criteria for insomnia, whereas at ages 8, 10, 12 and 14 years the prevalence ranged from 7.5% to 12.3%. During the 10-year period examined nearly 1 in 5 children had insomnia at least once (18.7%). Sex differences were apparent with DSM-IV, but not DSM-5, criteria: boys (8.1%) had more insomnia than girls (4.5%) did at ages 4–10 years, whereas girls (11.4%) had more insomnia than boys (7.1%) did at ages 12 and 14 years. Insomnia proved stable, with 22.9%–40.1% of children retaining their diagnosis 2 years later. Having current insomnia produced medium to large ORs of between 5.1 (95% CI 2.6 to 9.8) and 15.3 (95% CI 4.4 to 52.9) for subsequent insomnia 2 years later compared with not having preceding insomnia.ConclusionsInsomnia was less prevalent than previous research indicates, with nearly 1 in 5 participants having insomnia at least once between the ages of 4 and 14 years. Female preponderance emerged in early adolescence. Having insomnia at one time point was a considerable risk for subsequent insomnia, indicating that insomnia is persistent and warrants clinical attention.

Diagnosis of Attention Deficit Disorders in DSM-IV: Scientific Basis and Implications for Education

1993 ◽  
Vol 60 (2) ◽  
pp. 108-117 ◽  
Author(s):  
Keith McBurnett ◽  
Benjamin B. Lahey ◽  
Linda J. Pfiffner
Keyword(s):  
Attention Deficit ◽  
Field Trials ◽  
Scientific Basis ◽  
Statistical Manual ◽  
Hyperactivity Disorder ◽  
Diagnostic And Statistical Manual ◽  
History Of ◽  
Dsm Iv ◽  
Symptom List

The category of attention deficit hyperactivity disorder (ADHD) and its diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM) have undergone numerous revisions. The history of these revisions is briefly presented, followed by a summary of results of the Field Trials for the forthcoming fourth edition, the DSM-IV, regarding ADHD. The revised symptom list and empirical determination of symptom cutpoints resulted in increased reliability and predictive validity for educational impairment, as operationalized by measures of academic productivity and accuracy, for the new criteria. Three subtypes emerged, including a new subtype of predominantly hyperactive. The relevance, functions, and limitations of DSM-IV diagnosis for educational assessment of ADHD are discussed.

Profile of two hundred children with Autism Spectrum Disorder from a tertiary child and adolescent psychiatry centre

2017 ◽  
Vol 28 ◽  
pp. 51-56 ◽  
Author(s):  
John Vijay Sagar Kommu ◽  
Gayathri K.R. ◽  
Shoba Srinath ◽  
Satish Chandra Girimaji ◽  
Shekhar P. Seshadri ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Adolescent Psychiatry ◽  
Children With Autism ◽  
Child And Adolescent ◽  
Autism Spectrum ◽  
Child And Adolescent Psychiatry ◽  
Spectrum Disorder

To ID or Not to ID? Changes in Classification Rates of Intellectual Disability Using DSM-5

2014 ◽  
Vol 52 (3) ◽  
pp. 165-174 ◽  
Author(s):  
Aimilia Papazoglou ◽  
Lisa A. Jacobson ◽  
Marie McCabe ◽  
Walter Kaufmann ◽  
T. Andrew Zabel
Keyword(s):  
Intellectual Disability ◽  
Clinical Judgment ◽  
Assessment System ◽  
Statistical Manual ◽  
Diagnostic And Statistical Manual ◽  
Dsm 5 ◽  
Adaptive Behavior Assessment System ◽  
Dsm Iv ◽  
Definition Of ◽  
Adaptive Skill

Abstract The Diagnostic and Statistical Manual of Mental Disorders—Fifth Edition (DSM-5) diagnostic criteria for intellectual disability (ID) include a change to the definition of adaptive impairment. New criteria require impairment in one adaptive domain rather than two or more skill areas. The authors examined the diagnostic implications of using a popular adaptive skill inventory, the Adaptive Behavior Assessment System–Second Edition, with 884 clinically referred children (ages 6–16). One hundred sixty-six children met DSM-IV-TR criteria for ID; significantly fewer (n  =  151, p  =  .001) met ID criteria under DSM-5 (9% decrease). Implementation of DSM-5 criteria for ID may substantively change the rate of ID diagnosis. These findings highlight the need for a combination of psychometric assessment and clinical judgment when implementing the adaptive deficits component of the DSM-5 criteria for ID diagnosis.

From DSM-IV to DSM-5: an interim report from a cultural psychiatry perspective

2013 ◽  
Vol 37 (5) ◽  
pp. 171-174 ◽  
Author(s):  
Neil Krishan Aggarwal
Keyword(s):  
American Psychiatric Association ◽  
Scientific Evidence ◽  
Evidence Base ◽  
Cultural Psychiatry ◽  
Statistical Manual ◽  
Cultural Validity ◽  
Cultural Assumptions ◽  
Diagnostic And Statistical Manual ◽  
Dsm 5 ◽  
Dsm Iv

SummaryIn July 2012, the American Psychiatric Association (APA) closed its final commenting period on draft criteria for the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), slated for publication in May 2013. DSM-5 raises familiar questions about the cultural assumptions of proposed diagnoses, the scientific evidence base of these criteria and their validity in international settings. I review these issues since the publication of DSM-IV. I assess the cultural validity of DSM-5 and suggest areas of improvement.

Sign in / Sign up

Export Citation Format

Share Document